Top Wall Street analysts changed outlook on top names. ADCT downgraded See analysts' views.

Discover why ADC Therapeutics (NYSE:ADCT) stock is tumbling on Friday as a prominent Wall Street analyst slashes targets due to serious trial safety signals.

Top Wall Street analysts changed outlook on top names. ADCT downgraded See analysts' views.